Management of acute mastoiditis in children: a retrospective analysis

Marella Reale1, Carlotta Montagnani2, Pietro Orlando3

  • 1Otorhinolaryngology Unit, Head and Neck Department, Meyer Children's Hospital IRCCS, Florence, Italy.

PubMed

Insights

Acute mastoiditis (AM) and complicated AM (CAM) are serious ear infection complications. Elevated CRP levels indicate higher CAM risk, while most AM cases are treated medically, unlike CAM which often requires surgery.

Area of Science:

  • Pediatric Otolaryngology
  • Infectious Diseases

Background:

  • Acute mastoiditis (AM) is a common complication of acute otitis media (AOM).
  • There is no established consensus on the diagnostic or therapeutic management of AM.
  • AM can lead to severe complications if not promptly diagnosed and treated.

Purpose of the Study:

  • To analyze the management of children with AM and complicated AM (CAM).
  • To evaluate differences in clinical presentation and management between AM and CAM.
  • To outline a potential diagnostic and therapeutic pathway for AM and CAM.
  • To assess the incidence of AM over time.

Main Methods:

  • Retrospective study of pediatric patients admitted for AM or CAM.
  • Data collected from January 2016 to December 2023 at Meyer University Hospital- IRCCS, Florence.
  • Analysis of clinical presentation, microbiological findings, management, and outcomes.

Main Results:

  • Eighty-five patients (60% male, median age 4 years) were included.
  • Pseudomonas aeruginosa was the most frequent pathogen in AM, Streptococcus pyogenes in CAM.
  • Seventeen patients developed CAM; elevated CRP levels were associated with increased CAM risk (p=0.043).
  • AM management was primarily medical (IV antibiotics); surgery was rare (1/68).
  • CAM management frequently required surgery (76%), often mastoidectomy with abscess drainage.
  • A significant increase in AM cases was observed during the study period, particularly in 2023.

Conclusions:

  • AM and CAM are infrequent but potentially life-threatening AOM complications.
  • A rise in AM cases in 2023 may be linked to the lifting of pandemic restrictions.
  • Management of mastoiditis is heterogeneous, even within a single institution.
  • Elevated CRP is the sole identified predictor of complicated mastoiditis.
  • Guidelines are needed to support prompt diagnosis and effective management of AM and CAM.
Abstract